Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
November 5, 2012
Emergent BioSolutions Announces Acceptance of TRU-016 and Bispecific Abstracts for Presentation at 2012 American Society of Hematology Annual Meeting
...
Read More
November 1, 2012
Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2012
...
Read More
November 1, 2012
Emergent BioSolutions Announces Growth Plan Through 2015
...
Read More
October 31, 2012
Emergent BioSolutions Initiates Phase 1b Study of TRU-016 in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia
...
Read More
October 9, 2012
Emergent BioSolutions to Release Third Quarter 2012 Financial Results and Conduct a Conference Call on November 1, 2012
...
Read More
October 4, 2012
BARDA Exercises Contract Option as Emergent BioSolutions Achieves Significant Progress in rPA Anthrax Vaccine Development
...
Read More
August 28, 2012
Emergent BioSolutions to Present at ThinkEquity’s 9th Annual Growth Conference
...
Read More
August 8, 2012
Emergent BioSolutions to Present at Wedbush 2012 Life Sciences Management Access Conference
...
Read More
August 2, 2012
Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2012
...
Read More
July 9, 2012
Emergent BioSolutions to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 2, 2012
...
Read More
June 18, 2012
BARDA and Emergent BioSolutions Partner to Establish Center for Innovation in Advanced Development and Manufacturing
...
Read More
June 4, 2012
Emergent BioSolutions Secures Additional Funding from BARDA to Pursue Post-Exposure Prophylaxis Indication for BioThrax
...
Read More
1
2
…
38
39
40
…
58
59
